M. Epinat

发表

Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old.

S. Laporte, P. Zufferey, H. Décousus, 2007, British journal of clinical pharmacology.

Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke

E. Vicaut, D. Leys, A. Leger, 2020, Stroke.

Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta‐analysis

S. Laporte, M. Cucherat, P. Zufferey, 2004, Journal of thrombosis and haemostasis : JTH.

Platelet transmission electron microscopy for the assessment of poor biological response to antiplatelet agent: pilot descriptive and prospective study - ELECTROSTROKE

P. Mismetti, Guorong Li, P. Garnier, 2022, BMJ Open.

Assessment of a flow cytometry technique for studying signaling pathways in platelets: Monitoring of VASP phosphorylation in clinical samples

C. Lambert, P. Mismetti, P. Garnier, 2018, Practical laboratory medicine.

Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis.

S. Laporte, A. Leizorovicz, H. Décousus, 2003, Journal of vascular surgery.

Superficial vein thrombosis: risk factors, diagnosis, and treatment

C. Boissier, H. Décousus, B. Tardy, 2003, Current opinion in pulmonary medicine.

Superficial vein thrombosis

C. Boissier, H. Décousus, B. Tardy, 2003 .

The location of deep-vein thrombosis as a predictive factor for recurrence and cancer discovery after proximal deep-vein thrombosis.

S. Laporte, H. Décousus, P. Mismetti, 2003, Haematologica.

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis

L. Bertoletti, A. Lurkin, P. Mismetti, 2019, Cerebrovascular Diseases.

Monitoring of biological response to clopidogrel after treatment for non-cardioembolic ischemic stroke or transient ischemic attack.

C. Lambert, P. Mismetti, Guorong Li, 2019, American journal of translational research.

Role of platelet α2-adrenoreceptor in biological low response to Clopidogrel for patients with non cardioembolic ischemic stroke or transient ischemic attack.

C. Boutet, S. Laporte, C. Chapelle, 2018, American journal of translational research.

A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism.

F. Barral, S. Laporte, H. Décousus, 2007, Chest.

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

D. Tanné, D. Blacker, S. Connolly, 2018, The Lancet. Neurology.

Brain magnetic resonance imaging findings in cryptogenic stroke patients under 60 years with patent foramen ovale.

F. Schneider, F. Barral, C. Boutet, 2014, European journal of radiology.

[New oral anticoagulants in nonvalvular atrial fibrillation].

S. Laporte, L. Bertoletti, J. Lega, 2013, Presse medicale.

Tetraparesia with areflexia revealing cerebral venous thrombosis.

P. Garnier, M. Epinat, T. Atroun, 2013, Revue neurologique (Paris).

Superficial vein thrombosis: risk factors, diagnosis, and treatment

C. Boissier, H. Décousus, B. Tardy, 2003, Current opinion in pulmonary medicine.